BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16470369)

  • 1. Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer.
    Duong CP; Demitriou H; Weih L; Thompson A; Williams D; Thomas RJ; Hicks RJ
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):759-69. PubMed ID: 16470369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer.
    Duong CP; Hicks RJ; Weih L; Drummond E; Leong T; Michael M; Thomas RJ
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):770-8. PubMed ID: 16550384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data.
    Barber TW; Duong CP; Leong T; Bressel M; Drummond EG; Hicks RJ
    J Nucl Med; 2012 Jun; 53(6):864-71. PubMed ID: 22582047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment.
    Bombardieri E
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):753-8. PubMed ID: 16733687
    [No Abstract]   [Full Text] [Related]  

  • 5. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
    Choi JY; Jang HJ; Shim YM; Kim K; Lee KS; Lee KH; Choi Y; Choe YS; Kim BT
    J Nucl Med; 2004 Nov; 45(11):1843-50. PubMed ID: 15534053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of initial fluorodeoxyglucose-PET in esophageal cancer: a prospective study.
    Cheze-Le Rest C; Metges JP; Teyton P; Jestin-Le Tallec V; Lozac'h P; Volant A; Visvikis D
    Nucl Med Commun; 2008 Jul; 29(7):628-35. PubMed ID: 18528185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer.
    Hicks RJ; Kalff V; MacManus MP; Ware RE; Hogg A; McKenzie AF; Matthews JP; Ball DL
    J Nucl Med; 2001 Nov; 42(11):1596-604. PubMed ID: 11696627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors.
    Eschmann SM; Friedel G; Paulsen F; Reimold M; Hehr T; Scheiderbauer J; Budach W; Kotzerke J; Bares R
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):54-9. PubMed ID: 16896660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of novel ¹⁸F-FDG PET/CT defined tumour variables in patients with oesophageal cancer.
    Foley KG; Fielding P; Lewis WG; Karran A; Chan D; Blake P; Roberts SA
    Eur J Radiol; 2014 Jul; 83(7):1069-1073. PubMed ID: 24794862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
    Kalff V; Duong C; Drummond EG; Matthews JP; Hicks RJ
    J Nucl Med; 2006 Jan; 47(1):14-22. PubMed ID: 16391182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT as a potential predictor of survival in patient with oesophageal cancer: a preliminary result.
    Fathinul Fikri AS; Dharmendran R; Vikneswaran P; Nordin AJ
    Abdom Imaging; 2015 Aug; 40(6):1457-64. PubMed ID: 25576048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study.
    Chatterton BE; Ho Shon I; Baldey A; Lenzo N; Patrikeos A; Kelley B; Wong D; Ramshaw JE; Scott AM
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):354-61. PubMed ID: 18931839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer?
    Torrance AD; Almond LM; Fry J; Wadley MS; Lyburn ID
    Surgeon; 2015 Feb; 13(1):19-33. PubMed ID: 24206935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of PET/CT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data.
    Gregory DL; Hicks RJ; Hogg A; Binns DS; Shum PL; Milner A; Link E; Ball DL; Mac Manus MP
    J Nucl Med; 2012 Jul; 53(7):1007-15. PubMed ID: 22677701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience.
    Siva S; Byrne K; Seel M; Bressel M; Jacobs D; Callahan J; Laing J; Macmanus MP; Hicks RJ
    J Nucl Med; 2013 Aug; 54(8):1223-9. PubMed ID: 23753187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival.
    Marcus C; Antoniou A; Rahmim A; Ladenson P; Subramaniam RM
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):281-8. PubMed ID: 25676871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Staging with 18F-FDG-PET/CT influences stage-specific survival in advanced non-small cell lung cancer (NSCLC)].
    Tönnies S; Bauer TT; Misch D; Boch C; Blum T; Bittner RC; Förster GJ; Kollmeier J
    Pneumologie; 2012 Apr; 66(4):212-7. PubMed ID: 22477481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer.
    Davey K; Heriot AG; Mackay J; Drummond E; Hogg A; Ngan S; Milner AD; Hicks RJ
    Dis Colon Rectum; 2008 Jul; 51(7):997-1003. PubMed ID: 18461399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy.
    Onal C; Torun N; Guler OC; Yildirim BA
    Nucl Med Commun; 2016 Dec; 37(12):1282-1289. PubMed ID: 27612030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F-FDG-PET in therapy response of esophageal cancer].
    Wieder HA; Herrmann K; Ott K; Krause BJ
    Radiologe; 2007 Feb; 47(2):110-4. PubMed ID: 17225182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.